# Caladrius Biosciences Inc. (CLBS)

Source: https://www.quantisnow.com/company/CLBS
Generated: 2026-11-11T15:48:36.881Z

- Ticker: CLBS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Managed Health Care
- Website: caladrius.com

## About

Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; OLOGO, a regenerative medicine advanced therapy for treating no-option refractory disabling angina; CLBS16 that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

## Latest CLBS news and filings

- 2023-01-17 22:05 UTC [SEC Form 4] [SEC Form 4: Mazzo David J covered exercise/tax liability with 397 shares, decreasing direct ownership by 0.41% to 96,543 units](https://www.quantisnow.com/insight/sec-form-4-mazzo-david-j-covered-exercisetax-liability-with-3919869)
- 2023-01-12 21:02 UTC [SEC Form 4] [SEC Form 4: Mazzo David J covered exercise/tax liability with 1,030 shares, decreasing direct ownership by 1% to 96,940 units](https://www.quantisnow.com/insight/sec-form-4-mazzo-david-j-covered-exercisetax-liability-with-3906846)
- 2023-01-11 21:20 UTC [SEC Form 4] [SEC Form 4: Ruoslahti Erkki was granted 20,000 shares](https://www.quantisnow.com/insight/sec-form-4-ruoslahti-erkki-was-granted-20000-shares-3902064)
- 2023-01-11 21:18 UTC [SEC Form 4] [SEC Form 4: Klosk Steven M was granted 20,000 shares, increasing direct ownership by 198% to 30,090 units](https://www.quantisnow.com/insight/sec-form-4-klosk-steven-m-was-granted-20000-shares-3902045)
- 2023-01-11 21:17 UTC [SEC Form 4] [SEC Form 4: Henson Heidi was granted 20,000 shares](https://www.quantisnow.com/insight/sec-form-4-henson-heidi-was-granted-20000-shares-3902020)
- 2023-01-11 21:15 UTC [SEC Form 4] [SEC Form 4: Flowers Cynthia Louise was granted 20,000 shares, increasing direct ownership by 206% to 29,721 units](https://www.quantisnow.com/insight/sec-form-4-flowers-cynthia-louise-was-granted-20000-shares-3901990)
- 2023-01-11 21:13 UTC [SEC Form 4] [SEC Form 4: Brown Gregory B was granted 20,000 shares, increasing direct ownership by 201% to 29,934 units](https://www.quantisnow.com/insight/sec-form-4-brown-gregory-b-was-granted-20000-shares-3901931)
- 2023-01-11 21:12 UTC [SEC Form 4] [SEC Form 4: Azab Mohammad was granted 20,000 shares, increasing direct ownership by 104% to 39,200 units](https://www.quantisnow.com/insight/sec-form-4-azab-mohammad-was-granted-20000-shares-increasing-3901916)
- 2023-01-11 21:10 UTC [SEC Form 4] [SEC Form 4: Slack David W. was granted 24,000 shares and covered exercise/tax liability with 3,358 shares](https://www.quantisnow.com/insight/sec-form-4-slack-david-w-was-granted-24000-shares-3901892)
- 2023-01-11 21:07 UTC [SEC Form 4] [SEC Form 4: Mazzo David J was granted 60,000 shares and covered exercise/tax liability with 11,315 shares, increasing direct ownership by 99% to 97,970 units](https://www.quantisnow.com/insight/sec-form-4-mazzo-david-j-was-granted-60000-shares-3901862)
- 2023-01-11 21:03 UTC [SEC Form 4] [SEC Form 4: Buck Kristen K was granted 18,000 shares and covered exercise/tax liability with 2,659 shares, increasing direct ownership by 75% to 35,823 units](https://www.quantisnow.com/insight/sec-form-4-buck-kristen-k-was-granted-18000-shares-3901794)
- 2022-11-10 21:12 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Caladrius Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-caladrius-biosciences-inc-3667773)
- 2022-11-10 21:10 UTC [SEC Form 8-K] [Caladrius Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/caladrius-biosciences-inc-filed-sec-form-8-k-results-of-operations-3667640)
- 2022-10-17 20:02 UTC [SEC Form S-8] [SEC Form S-8 filed by Caladrius Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-caladrius-biosciences-inc-3540119)
- 2022-10-14 20:01 UTC [SEC Form 8-K] [Caladrius Biosciences Inc. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/caladrius-biosciences-inc-filed-sec-form-8-k-financial-statements-and-3534523)
- 2022-10-04 20:42 UTC [SEC Form 8-K] [Caladrius Biosciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/caladrius-biosciences-inc-filed-sec-form-8-k-other-events-financial-3493517)
- 2022-09-29 20:01 UTC [SEC Form 8-K] [Caladrius Biosciences Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/caladrius-biosciences-inc-filed-sec-form-8-k-other-events-3473748)
- 2022-09-26 20:20 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Caladrius Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-caladrius-biosciences-inc-3454181)
- 2022-09-22 20:02 UTC [SEC Form 8-K] [Caladrius Biosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/caladrius-biosciences-inc-filed-sec-form-8-k-regulation-fd-disclosure-3444024)
- 2022-09-16 20:51 UTC [SEC Form 3] [SEC Form 3 filed by new insider Slack David W.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-slack-david-w-3422671)
- 2022-09-16 20:50 UTC [SEC Form 3] [SEC Form 3: New insider Ruoslahti Erkki claimed ownership of 1,171,144 shares](https://www.quantisnow.com/insight/sec-form-3-new-insider-ruoslahti-erkki-claimed-ownership-of-3422665)
- 2022-09-16 20:48 UTC [SEC Form 3] [SEC Form 3 filed by new insider Henson Heidi](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-henson-heidi-3422654)
- 2022-09-16 20:46 UTC [SEC Form 4] [SEC Form 4: Azab Mohammad was granted 19,200 shares](https://www.quantisnow.com/insight/sec-form-4-azab-mohammad-was-granted-19200-shares-3422645)
- 2022-09-16 20:45 UTC [SEC Form 3] [SEC Form 3 filed by new insider Azab Mohammad](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-azab-mohammad-3422636)
- 2022-09-15 13:16 UTC [SEC Form 8-K] [Caladrius Biosciences Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/caladrius-biosciences-inc-filed-sec-form-8-k-completion-of-acquisition-3415880)
- 2022-09-15 13:15 UTC [Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics](https://www.quantisnow.com/insight/caladrius-biosciences-and-cend-therapeutics-announce-closing-of-merger-and-3415850)
- 2022-09-15 09:21 UTC [Market Insight] [Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday](https://www.quantisnow.com/insight/why-vintage-wine-estates-shares-tumbled-40-here-are-70-3413938)
- 2022-09-14 21:01 UTC [SEC Form 8-K] [Caladrius Biosciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/caladrius-biosciences-inc-filed-sec-form-8-k-amendments-to-articles-3412992)
- 2022-09-14 17:33 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-intraday-session-3411761)
- 2022-09-14 16:30 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Wednesday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-wednesday-3411477)
- 2022-09-14 16:28 UTC [Market Insight] [Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-scisparc-is-trading-higher-by-68-here-are-48-3411457)
- 2022-09-14 14:09 UTC [Market Insight] [Ten Stocks Trending on Discord for Wednesday September 14, 2022: ADTX, ALT, KERN, CLBS, NRBO, TSLA, NVDA, MTP, AVCT, META](https://www.quantisnow.com/insight/ten-stocks-trending-on-discord-for-wednesday-september-14-2022-3410668)
- 2022-09-14 12:32 UTC [Market Chatter] [Caladrius Biosciences shares are trading higher after the company announced approval of all the merger-related proposals and a name change to Lisata Therapeutics.](https://www.quantisnow.com/insight/caladrius-biosciences-shares-are-trading-higher-after-the-company-announced-3409714)
- 2022-09-14 12:11 UTC [Market Chatter] [Caladrius Biosciences Announces Approval Of Merger And Name Change To Lisata Therapeutics](https://www.quantisnow.com/insight/caladrius-biosciences-announces-approval-of-merger-and-name-change-to-3409533)
- 2022-09-14 12:00 UTC [Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics](https://www.quantisnow.com/insight/caladrius-biosciences-announces-approval-of-merger-and-name-change-to-3409304)
- 2022-09-08 12:00 UTC [Conference Announcement] [Caladrius Biosciences Announces Participation in Upcoming Investor Conferences in September 2022](https://www.quantisnow.com/insight/caladrius-biosciences-announces-participation-in-upcoming-investor-conferences-in-september-3387311)
- 2022-09-02 20:05 UTC [SEC Form 4] [SEC Form 4: Buck Kristen K was granted 58,000 shares and covered exercise/tax liability with 69,959 shares, decreasing direct ownership by 4% to 307,244 units](https://www.quantisnow.com/insight/sec-form-4-buck-kristen-k-was-granted-58000-shares-3371317)
- 2022-09-02 20:03 UTC [SEC Form 4] [SEC Form 4: Mazzo David J was granted 150,000 shares and covered exercise/tax liability with 69,742 shares, increasing direct ownership by 12% to 739,444 units](https://www.quantisnow.com/insight/sec-form-4-mazzo-david-j-was-granted-150000-shares-3371275)
- 2022-09-02 20:01 UTC [SEC Form 425] [SEC Form 425 filed by Caladrius Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-caladrius-biosciences-inc-3371236)
- 2022-09-02 12:07 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-pre-market-session-3368970)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CLBS
- Earnings history: https://www.quantisnow.com/earnings/CLBS
- Dividend history: https://www.quantisnow.com/dividends/CLBS
- Insider transactions: https://www.quantisnow.com/insiders/CLBS
- Options chain: https://www.quantisnow.com/options/CLBS
- SEC 8-K filings only: https://www.quantisnow.com/company/CLBS/8-k
- RSS and alerts for CLBS: https://www.quantisnow.com/docs/rss-feeds.md